Trial Profile
Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2013
Price :
$35
*
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTaP poliovirus vaccine; Hepatitis B vaccine recombinant
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 15 Dec 2009 Planned number of patients (186) added as reported by ClinicalTrials.gov.
- 15 Dec 2009 Planned number of patients (186) added as reported by ClinicalTrials.gov.
- 10 Dec 2009 Booster trial (NCT01031303) identified and integrated.